Fig. 4

A hAMSC administration decreases the number of CD11b⁺CD45⁺ cells, Ly6C⁺ and Ly6G⁺ cells in the ICH lesions. A Representative gating strategy of the flow cytometry for CD11b CD45 Ly6C Ly6G cells. Data were obtained from the ICH lesions at Days 2, 4 and, 8. B The total cell number. C The number of CD11b⁺CD45⁺ cells. D The number of CD11b⁺CD45⁺Ly6C⁺Ly6G⁻ cells. E The number of CD11b⁺CD45⁺Ly6C⁻Ly6G⁺ cells. Data are plotted in mean ± SEM. P values are based on the Wilcoxon test. *P < 0.05 compared with the ICH group